Genetic characterization and clinical outcome of melanoma of unknown primary (MUP) with comparison to melanoma with known primary (MKP)Georg Lodde, E. Livingstone, P. Terheyden et al.|EJC Skin Cancer|2025Cited by 0
COMBI-EU: Real-World Evidence on Adverse Event Management and Time on Therapy with Adjuvant Dabrafenib Plus Trametinib in Patients with BRAF V600-Mutant MelanomaMichael Weichenthal, Dirk Schadendorf, Dirk Debus et al.|Cancers|2026Cited by 0